Xin Lang Cai Jing·2025-11-14 01:50Core Insights - Spring Medical's stock price has increased by 121.32% year-to-date, with a recent 6.01% rise over the past five trading days [2] - The company reported a revenue of 756 million yuan for the first nine months of 2025, representing a year-on-year growth of 48.75%, and a net profit of 192 million yuan, up 213.21% year-on-year [3] Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices [2] - The company's main products include joint prosthetics and spinal implants, with a revenue composition of 99.89% from medical device products [2] Stock Performance - As of November 14, the stock price reached 28.22 yuan per share, with a market capitalization of 10.824 billion yuan [1] - The stock has shown significant price increases over various time frames: 6.01% over the last five days, 13.56% over the last 20 days, and 20.96% over the last 60 days [2] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average number of circulating shares per person decreased by 3.95% [3] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [4] Institutional Holdings - Notable new institutional shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed Fund, holding 2.9585 million shares and 2.8326 million shares, respectively [4] - The South China Medical Health Flexible Allocation Mixed Fund has exited the top ten circulating shareholders list [4]